Adding dendritic cell-immunotherapy for post-transplant hepatocellular carcinoma recurrence

BackgroundHepatocellular carcinoma (HCC) recurrence after liver transplantation is frequently multiple and extrahepatic, and with a poor prognosis. The therapeutic effects of current medications for post-transplant HCC recurrence are limited. This study assessed whether outcomes could be improved by...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Wei-Chen Lee, Chih-Hsien Cheng, Tsung-Han Wu, Yu-Chao Wang, Jin-Chiao Lee, Hao-Chien Hung, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou, Kun-Ming Chan
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2025-08-01
Σειρά:	Frontiers in Immunology
Θέματα:	DC dendritic cell hepatocellular carcinoma liver transplantation tyrosine kinase inhibitor immune checkpoint inhibitor
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1589634/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!